urolithiasis. Calculus of kidney and ureter
Conditions
Interventions
Intervention 1: Phase 1: Oral solution of potassium citrate, 0.5 cc/kg/dose, every 8 hours, 30 min after meal, for 4 weeks. Intervention 2: Phase 2: Combination of K Citrate 0.5 cc/kg/dose, every 8 ho
Treatment - Drugs
Phase 1: Oral solution of potassium citrate, 0.5 cc/kg/dose, every 8 hours, 30 min after meal, for 4 weeks
Phase 2: Combination of K Citrate 0.5 cc/kg/dose, every 8 hours, 30 min after meal as well as Mg Chloride 10-20 mg/kg/dose equivalent to 180 meq elemental Mg for 4 weeks
Sponsors
Isfahan University of Medical Sciences and Health Services
Eligibility
Sex/Gender
Male
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 2-12 years with possibility of calcium oxalate kidney stone, No past history of peptic ulcer, chronic diarrhea or cardiac disease, primary hyperparathyroidism, consumption of anticonvulsants, No proven history of disorders affecting tubular ion excretion such as: recent urinary tract infection , distal renal tubular acidosis , chronic pyelonephritis, renal dysfunction and obstructive uropathy Exclusion criteria: Patients who did not complete all steps of the study, refusing to consume either potassium citrate or magnesium chloride
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood parameter (Ca-K-Na-Cl-Cit-Ox-P-Cr-Mg). Timepoint: Before and 4 weeks after intervention. Method of measurement: blood test.;Urine parameter (Ca-K-Na-Cl-Cit-Ox-P-Cr-Mg). Timepoint: Before and4 weeks after intervention. Method of measurement: 24-hour urine test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Alaleh Gheisary
Isfahan University of Medical Sciences and Health Services
Outcome results
None listed